+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Thematic Intelligence: Telemedicine - Physician Perspective

  • PDF Icon

    Report

  • 66 Pages
  • June 2024
  • Region: Global
  • GlobalData
  • ID: 5987419
As a result of the pandemic, regulations and policies governing reimbursement and use of telemedicine have changed significantly, leading to expanded access and an unprecedented demand for these services. However, after experiencing a substantial surge in usage since early 2020, the demand for telemedicine started to wear off, influenced by factors like easing of pandemic restrictions, increased access to in-person healthcare services and withdrawal of some emergency legislation that initially prompted the widespread adoption of telemedicine. In this report, The analyst assesses the telemedicine uptake in the 8MM and examines the healthcare provider’s perspective on its further integration into conventional healthcare practices.
  • Telemedicine adoption was on the rise before COVID-19, but its uptake was still relatively low.
  • Use of telemedicine surged during COVID-19 as a result of social distancing and lockdown measures.
  • Post-COVID-19, the uptake of telemedicine slowed, but its peak is still yet to be reached.
  • The main barriers to wider use of telemedicine are lack of awareness and a preference for in-person care.
  • Telemedicine’s value in patient care is recognized by the healthcare professionals.
  • Physicians have reservations regarding their patients’ comfort with using telemedicine.
  • Telemedicine treats more patients with fewer clinicians.
  • When feasible, the use of telemedicine should be a choice, rather than a compulsory requirement.

Scope

  • The report provides an overview of how virtual care and telemedicine have revolutionized the healthcare industry.
  • The report reviews various segments within the virtual care and telemedicine value chain (patient seeking healthcare services, healthcare services, and electronic medical records) for market players to invest, explore, or ignore.
  • It offers virtual care and telemedicine timelines and use cases for a better understanding of the theme.

Reasons to Buy

  • Develop and design your corporate strategies through an in-house expert analysis of virtual care and telemedicine by understanding the primary ways in which this theme is impacting the healthcare industry.
  • Identify emerging industry trends to gain a competitive advantage.

Table of Contents

1. Executive Summary

2. Study Design

3. Telemedicine Overview

4. Telemedicine Sector in the US, Europe, China, and Japan Before and During COVID-19

5. Telemedicine Sector in the US, Europe, China, and Japan After COVID-19

6. Acceptance of Telemedicine Among Physicians and Patients

7. Future Considerations

8. Summary of Key Findings

9. Appendix

10. About the Authors

11. Contact the Publisher

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Microsoft Corp
  • CareCloud Inc
  • Teladoc Health Inc
  • Skype Limited
  • Best Doctors Inc
  • Philips
  • drchrono Inc
  • Updox LLC
  • HealthTap Inc
  • DrFirst Inc
  • American Well Corp
  • MDLIVE Inc
  • Livongo Health Inc
  • Chiron Health, Inc.
  • New York Stock Exchange LLC
  • VSee Lab Inc
  • eVisit Inc
  • InTouch Health
  • PlushCare Inc
  • Doctor On Demand Inc
  • Cisco
  • Medici
  • Doxy Me LLC
  • BetterHelp
  • Goodrx Inc
  • Lemonaide